Trial intelligence / Profile preview

Ciprofol vs propofol for laryngeal mask general anesthesia in day surgery

ChiCTR2200065474Phase 4Recruiting

Sponsor
Hunan Provincial People's Hospital
Start
Dec 2021
Modality
Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of ciprofol in gynaecological conditions, genitourinary diseases (GU) and musculoskeletal condition (MSK) (2 arms), sponsored by Hunan Provincial People's Hospital. Primary endpoints: Injection pain, Time to MOAA/S ≤ 1 and 6 more. Started Dec 2021; status: recruiting.

02

Drugs

ciprofol
03

Conditions

gynaecological conditionsgenitourinary diseases (GU)musculoskeletal condition (MSK)

Beyond the preview

Go deeper on ChiCTR2200065474.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2200065474.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call